LARGE CELL-CARCINOMA OF THE LUNG - PROGNOSTIC IMPLICATIONS OF HISTOPATHOLOGIC AND IMMUNOHISTOCHEMICAL SUBTYPING

被引:13
作者
ISHIDA, T
KANEKO, S
TATEISHI, M
OKA, T
MITSUDOMI, T
SUGIMACHI, K
HARA, N
OHTA, M
机构
[1] KYUSHU UNIV,FAC MED,DIV CLIN PATHOL,FUKUOKA 812,JAPAN
[2] NATL KYUSHU CANC CTR HOSP,DEPT CHEST SURG,FUKUOKA,JAPAN
关键词
differentiation; intercellular cohesion; large cell carcinoma; Lung cancer; subtyping;
D O I
10.1093/ajcp/93.2.176
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Fifty-four patients with large cell carcinoma of the lung were treated surgically, and the prognostic factors were examined histologically and immunohistochemically. Based on evidence of intercellular cohesion, as seen in the histologic results, the patients were placed into two subtypes, compact growth type and loose structure type. The survival rates were 46% and 28% at five years, respectively (P <0.05). Immunohistochemically, keratin, epithelial membrane antigen (EMA), secretory component, lactoferrin, and carcinoembryonic antigen (CEA), as histologic markers of epithelial differentiation, were detectable in large cell carcinoma of both types and more frequently in the compact growth type than in the loose structure type. The difference was significant in case of detection of keratin, EMA, and CEA (P <0.05). These observations suggest that a large cell carcinoma may differentiate into an adenocarcinoma or squamous cell carcinoma. The presence of intercellular cohesion and use of these markers reflect prognosis of the disease.
引用
收藏
页码:176 / 182
页数:7
相关论文
共 23 条
[1]  
ALBAIN KS, 1985, CANCER, V56, P1618, DOI 10.1002/1097-0142(19851001)56:7<1618::AID-CNCR2820560726>3.0.CO
[2]  
2-W
[3]  
[Anonymous], 1982, Am J Clin Pathol, V77, P123
[4]  
CARTER D, 1973, TUMORS LOWER RESPIRA, P148
[5]   FINE-STRUCTURE OF LARGE CELL UNDIFFERENTIATED CARCINOMA OF LUNG [J].
CHURG, A .
HUMAN PATHOLOGY, 1978, 9 (02) :143-156
[6]   LARGE CELL-CARCINOMA OF THE LUNG - ULTRASTRUCTURAL AND IMMUNOHISTOCHEMICAL FEATURES [J].
DELMONTE, VC ;
ALBERTI, O ;
SALDIVA, PHN .
CHEST, 1986, 90 (04) :524-527
[7]  
FLANAGAN CP, 1964, AM J MED, V36, P214
[8]  
FRIEDBERG EC, 1965, CANCER-AM CANCER SOC, V18, P259, DOI 10.1002/1097-0142(196502)18:2<259::AID-CNCR2820180219>3.0.CO
[9]  
2-F
[10]   CARCINOEMBRYONIC ANTIGEN IN HISTOPATHOLOGY - IMMUNOPEROXIDASE STAINING OF CONVENTIONAL TISSUE-SECTIONS [J].
GOLDENBERG, DM ;
SHARKEY, RM ;
PRIMUS, FJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1976, 57 (01) :11-22